{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:59:09Z","timestamp":1791395949338,"version":"4.3.3"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Breast cancer (BC) remains a major global health concern, with rising incidence and mortality rates. Early diagnosis of BC plays an important role in its prevention. However, number of clinically validated biomarkers that enable accurate and minimally invasive diagnosis are still insufficient. Epigenetic modifications, particularly hypermethylation-mediated inactivation of numerous tumor suppressor genes occur early in tumorigenesis and are detectable even before the clinical onset, making them promising candidates for early diagnosis. Therefore, this study aimed to identify breast cancer-associated epigenetically regulated genes with potential diagnostic and biological relevance. A set of forty genes that displayed both hypermethylation and downregulation in BC were initially identified through bioinformatics analysis of publicly available datasets. Based on Gene Ontology (GO) and Reactome pathway enrichment analyses, eight genes were subsequently shortlisted for experimental analysis. Among these eight genes,\n                    <jats:italic>LHX3<\/jats:italic>\n                    was significantly downregulated in both MCF-7 and MDA-MB-231 cells and in all tested BC tissue samples.\n                    <jats:italic>LHX3<\/jats:italic>\n                    promoter hypermethylation was found in 80% of tumor tissues, compared to 32% in matched normal tissues. Aberrant\n                    <jats:italic>LHX3<\/jats:italic>\n                    promoter methylation was significantly associated with metastasis status (P\u2009=\u20090.0002), with higher methylation in non-metastatic tumors, tumor size \u226420 mm (P\u2009=\u20090.002), and advanced tumor stage (P\u2009=\u20090.005). Given the complex pattern of these associations, findings were interpreted cautiously. Treatment with 5-aza-2\u2019-deoxycytidine reversed promoter hypermethylation and restored\n                    <jats:italic>LHX3<\/jats:italic>\n                    expression in MDA-MB-231 and MCF-7 cells. Additionally, ectopic expression of\n                    <jats:italic>LHX3<\/jats:italic>\n                    not only reduced migration and proliferation but also induced cell death in BC cells. Our study provided the first evidence of epigenetically induced silencing of\n                    <jats:italic>LHX3<\/jats:italic>\n                    and its anti-tumor role in BC. Furthermore, our findings support\n                    <jats:italic>LHX3<\/jats:italic>\n                    as a candidate epigenetically regulated biomarker with tumor-suppressive properties in BC; however, independent cohort validation, quantitative methylation assays, and stage\/subtype-stratified analyses are required before its diagnostic or prognostic utility can be established.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0357378","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:32:12Z","timestamp":1791394332000},"page":"e0357378","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative methylome and transcriptome analyses identify LHX3 as an epigenetically downregulated marker with tumor suppressive properties in breast cancer"],"prefix":"10.1371","volume":"21","author":[{"given":"Kokab","family":"Farooq","sequence":"first","affiliation":[{"name":"University of the Punjab","place":["Lahore, Pakistan"],"department":["School of Biological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheereen","family":"Gull","sequence":"additional","affiliation":[{"name":"University of the Punjab","place":["Lahore, Pakistan"],"department":["School of Biological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubia","family":"Farooq","sequence":"additional","affiliation":[{"name":"Shaukat Khanum Memorial Cancer Hospital & Research Centre","place":["Lahore, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-335X","authenticated-orcid":true,"given":"Muhammad Talal","family":"Amin","sequence":"additional","affiliation":[{"name":"Ghent University","place":["Ghent, Belgium"],"department":["Faculty of Bioscience Engineering"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Salman","family":"Anjum","sequence":"additional","affiliation":[{"name":"Forman Christian College, (A Chartered University)","place":["Lahore, Pakistan"]},{"name":"Roswell Park Comprehensive Cancer Center","place":["Buffalo, New York, United States of America"],"department":["Department of Oral Oncology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hassan","family":"Sarfraz","sequence":"additional","affiliation":[{"name":"Rheumatology and Musculoskeletal Sciences, Botnar Institute of Musculoskeletal Sciences, University of Oxford","place":["Oxford, United Kingdom"],"department":["Nuffield Department of Orthopaedics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz","family":"Ahmad","sequence":"additional","affiliation":[{"name":"College of Pharmacy, King Saud University","place":["Riyadh, Saudi Arabia"],"department":["Department of Clinical Pharmacy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Shahzad","sequence":"additional","affiliation":[{"name":"University of the Punjab","place":["Lahore, Pakistan"],"department":["School of Biological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"pone.0357378.ref001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"pone.0357378.ref002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/bios13030387","article-title":"Biomarker detection in early diagnosis of cancer: Recent achievements in point-of-care devices based on paper microfluidics","volume":"13","author":"B Erkocyigit","year":"2023","journal-title":"Biosensors"},{"issue":"1","key":"pone.0357378.ref003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: The potential role of epi-drug in cancer therapy","volume":"19","author":"Y Lu","year":"2020","journal-title":"Mol Cancer"},{"issue":"9","key":"pone.0357378.ref004","first-page":"1539","article-title":"Promoter methylation and the detection of breast cancer","volume":"20","author":"J Brooks","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"1","key":"pone.0357378.ref005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: Mechanism and clinical application","volume":"13","author":"C Hu","year":"2021","journal-title":"Clin Epigenetics"},{"key":"pone.0357378.ref006","doi-asserted-by":"crossref","first-page":"668309","DOI":"10.3389\/fcell.2021.668309","article-title":"BRCA1 and BRCA2 tumor suppressor function in meiosis","volume":"9","author":"Q Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"pone.0357378.ref007","doi-asserted-by":"crossref","DOI":"10.17582\/journal.pjz\/20250113172610","article-title":"HLF: A novel epigenetically regulated tumor suppressor and diagnostic biomarker in breast cancer","volume":"56","author":"K Farooq","year":"2025","journal-title":"Pak J Zool"},{"issue":"3","key":"pone.0357378.ref008","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molonc.2010.04.002","article-title":"The epigenetics of breast cancer","volume":"4","author":"J Jovanovic","year":"2010","journal-title":"Mol Oncol"},{"issue":"7","key":"pone.0357378.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236192","article-title":"SHISA3, an antagonist of the Wnt\/\u03b2-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer","volume":"15","author":"N Shahzad","year":"2020","journal-title":"PLoS One"},{"key":"pone.0357378.ref010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0925-4773(99)00314-7","article-title":"The LIM domain: Regulation by association","volume":"91","author":"I Bach","year":"2000","journal-title":"Mech Dev"},{"issue":"5","key":"pone.0357378.ref011","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3892\/or.2014.3112","article-title":"LIM homeobox transcription factors, a novel subfamily which plays an important role in cancer (review)","volume":"31","author":"X Wang","year":"2014","journal-title":"Oncol Rep"},{"issue":"3","key":"pone.0357378.ref012","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.bbrc.2017.12.135","article-title":"Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels","volume":"495","author":"K Miyashita","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"pone.0357378.ref013","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.molonc.2013.12.009","article-title":"LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling","volume":"8","author":"A Kuzmanov","year":"2014","journal-title":"Mol Oncol"},{"issue":"6","key":"pone.0357378.ref014","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.21037\/tcr-21-739","article-title":"Effect of LHX2 gene methylation level and its function on radiotherapy of cervical cancer","volume":"10","author":"R Yu","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"6","key":"pone.0357378.ref015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0092-8674(00)81704-3","article-title":"LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons","volume":"95","author":"K Sharma","year":"1998","journal-title":"Cell"},{"issue":"5264","key":"pone.0357378.ref016","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.272.5264.1004","article-title":"Specification of pituitary cell lineages by the LIM homeobox gene Lhx3","volume":"272","author":"HZ Sheng","year":"1996","journal-title":"Science"},{"issue":"2","key":"pone.0357378.ref017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-8674(02)00823-1","article-title":"LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions","volume":"110","author":"JP Thaler","year":"2002","journal-title":"Cell"},{"issue":"3","key":"pone.0357378.ref018","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3892\/or.2017.5833","article-title":"LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma","volume":"38","author":"X Lin","year":"2017","journal-title":"Oncol Rep"},{"issue":"1","key":"pone.0357378.ref019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12032-024-02585-1","article-title":"LHX3 promotes EMT in hepatoma cell through \u03b2-catenin\/TCF4 pathway","volume":"42","author":"J Xia","year":"2024","journal-title":"Med Oncol"},{"issue":"1","key":"pone.0357378.ref020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/CBM-182257","article-title":"LHX3 is an advanced-stage prognostic biomarker and metastatic oncogene in hepatocellular carcinoma","volume":"26","author":"B Huang","year":"2019","journal-title":"Cancer Biomark"},{"key":"pone.0357378.ref021","doi-asserted-by":"crossref","unstructured":"Lu C, Duan C, Bing H. LIM homeobox transcription factors as novel prognosis biomarkers in head and neck squamous cell carcinoma. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-1204015\/v1","DOI":"10.21203\/rs.3.rs-1204015\/v1"},{"issue":"5","key":"pone.0357378.ref022","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1369\/jhc.2009.953026","article-title":"Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues","volume":"57","author":"D Dietrich","year":"2009","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"pone.0357378.ref023","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cai2.30","article-title":"Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer","volume":"1","author":"P Gao","year":"2022","journal-title":"Cancer Innov"},{"key":"pone.0357378.ref024","article-title":"NCBI GEO: Archive for functional genomics data sets--update","volume":"41","author":"T Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"75","key":"pone.0357378.ref025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001875","article-title":"Breast cancer methylomes establish an epigenomic foundation for metastasis","volume":"3","author":"F Fang","year":"2011","journal-title":"Sci Transl Med"},{"issue":"11","key":"pone.0357378.ref026","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1073\/pnas.1013224108","article-title":"Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer","volume":"108","author":"D Sproul","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"pone.0357378.ref027","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2012-13-10-r84","article-title":"Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns","volume":"13","author":"D Sproul","year":"2012","journal-title":"Genome Biol"},{"issue":"12","key":"pone.0357378.ref028","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/emmm.201100801","article-title":"DNA methylation profiling reveals a predominant immune component in breast cancers","volume":"3","author":"S Dedeurwaerder","year":"2011","journal-title":"EMBO Mol Med"},{"issue":"8","key":"pone.0357378.ref029","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1158\/0008-5472.CAN-10-4026","article-title":"Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity","volume":"71","author":"VK Hill","year":"2011","journal-title":"Cancer Res"},{"issue":"2","key":"pone.0357378.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002517","article-title":"The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women\u2019s cancer","volume":"8","author":"J Zhuang","year":"2012","journal-title":"PLoS Genet"},{"issue":"19","key":"pone.0357378.ref031","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1158\/0008-5472.CAN-11-1630","article-title":"Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence","volume":"71","author":"MJ Fackler","year":"2011","journal-title":"Cancer Res"},{"key":"pone.0357378.ref032","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update","author":"BT Sherman","year":"2022","journal-title":"). Nucleic Acids Res"},{"key":"pone.0357378.ref033","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"M Gillespie","year":"2022","journal-title":"Nucleic Acids Research"},{"key":"pone.0357378.ref034","first-page":"532","article-title":"TRIzol: A new reagent for optimal single-step isolation of RNA","author":"D Simms","year":"1993","journal-title":"Focus"},{"issue":"4","key":"pone.0357378.ref035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"4","key":"pone.0357378.ref036","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2478\/s11756-021-00678-0","article-title":"Thermococcus kodakarensis-derived L-asparaginase: A candidate for the treatment of glioblastoma","volume":"76","author":"H Naz","year":"2021","journal-title":"Biologia"},{"key":"pone.0357378.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku1111","article-title":"The eukaryotic promoter database: Expansion of EPDnew and new promoter analysis tools","volume":"43","author":"R Dreos","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"10016","key":"pone.0357378.ref038","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(15)00774-6","article-title":"Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): A randomised controlled trial","volume":"387","author":"N Ohuchi","year":"2016","journal-title":"Lancet"},{"issue":"21","key":"pone.0357378.ref039","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.3390\/cancers14215444","article-title":"Classic and new markers in diagnostics and classification of breast cancer","volume":"14","author":"R Be\u0148a\u010dka","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"pone.0357378.ref040","first-page":"8319","article-title":"Analysis of differential gene expression caused by cervical intraepithelial neoplasia based on GEO database","volume":"15","author":"S Yao","year":"2018","journal-title":"Oncol Lett"},{"issue":"3","key":"pone.0357378.ref041","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41389-018-0034-x","article-title":"Double agents: Genes with both oncogenic and tumor-suppressor functions","volume":"7","author":"L Shen","year":"2018","journal-title":"Oncogenesis"},{"issue":"10","key":"pone.0357378.ref042","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1007\/s13277-014-2210-8","article-title":"Oncogenicity of LHX4 in colorectal cancer through Wnt\/\u03b2-catenin\/TCF4 cascade","volume":"35","author":"N Cha","year":"2014","journal-title":"Tumour Biol"},{"key":"pone.0357378.ref043","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2020.04.007","article-title":"Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR\/NF-\u03bab signaling","volume":"482","author":"J Chen","year":"2020","journal-title":"Cancer Lett"},{"issue":"3","key":"pone.0357378.ref044","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.3892\/mmr.2015.3997","article-title":"LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Z Hu","year":"2015","journal-title":"Mol Med Rep"},{"issue":"12","key":"pone.0357378.ref045","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/carcin\/bgr219","article-title":"Downregulation of alpha-fetoprotein expression by LHX4: A critical role in hepatocarcinogenesis","volume":"32","author":"T-M Hung","year":"2011","journal-title":"Carcinogenesis"},{"issue":"7","key":"pone.0357378.ref046","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1593\/neo.09406","article-title":"Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood","volume":"11","author":"V Vladimirova","year":"2009","journal-title":"Neoplasia"},{"issue":"1","key":"pone.0357378.ref047","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1210\/en.2005-0970","article-title":"Two promoters mediate transcription from the human LHX3 gene: Involvement of nuclear factor I and specificity protein 1","volume":"147","author":"BC Yaden","year":"2006","journal-title":"Endocrinology"},{"issue":"1","key":"pone.0357378.ref048","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"D Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"4","key":"pone.0357378.ref049","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s12253-018-00568-y","article-title":"Slit\/Robo signaling pathway in cancer; A new stand point for cancer treatment","volume":"25","author":"Z Koohini","year":"2019","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"pone.0357378.ref050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-023-04015-8","article-title":"Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner","volume":"21","author":"F Giordano","year":"2023","journal-title":"J Transl Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:32:21Z","timestamp":1791394341000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357378"}},"subtitle":[],"editor":[{"given":"Osman","family":"El-Maarri","sequence":"first","affiliation":[{"name":"University of Bonn, Institute of Experimental Hematology and Transfusion Medicine","place":["GERMANY"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357378","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}